Patents by Inventor Duane Larry Charbonneau

Duane Larry Charbonneau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200377961
    Abstract: The multiple embodiments described herein comprise the genome of a probiotic Bifidobacterium longum bifidobacteria strain and genes encoded by the genome. Various novel Bifidobacterium longum are described.
    Type: Application
    Filed: May 12, 2020
    Publication date: December 3, 2020
    Applicant: PrecisionBiotics Group Limited
    Inventors: Douwe Van Sinderen, Jun Xu, Wenzhu Zhao, Raymond A. Grant, Yuli Song, Charles Bascom, Duane Larry Charbonneau, Liam O'Mahony
  • Patent number: 10689719
    Abstract: The multiple embodiments described herein comprise the genome of a probiotic Bifidobacterium longum bifidobacteria strain and genes encoded by the genome. Various novel Bifidobacterium longum are described.
    Type: Grant
    Filed: August 23, 2017
    Date of Patent: June 23, 2020
    Assignee: PrecisionBiotics Group Limited
    Inventors: Douwe Van Sinderen, Jun Xu, Wenzhu Zhao, Raymond A. Grant, Yuli Song, Charles Bascom, Duane Larry Charbonneau, Liam O'Mahony
  • Publication number: 20180185207
    Abstract: The present disclosure describes disposable absorbent article(s) comprising a skin health composition effective for treating bacteria, including the bacteria associated with diaper rash.
    Type: Application
    Filed: February 27, 2018
    Publication date: July 5, 2018
    Inventors: Paul Thomas WEISMAN, Duane Larry CHARBONNEAU, Serena Rae HEYSE
  • Patent number: 9937087
    Abstract: The present disclosure describes disposable absorbent article(s) comprising a skin health composition effective for treating bacteria, including the bacteria associated with diaper rash.
    Type: Grant
    Filed: January 22, 2015
    Date of Patent: April 10, 2018
    Assignee: The Procter & Gamble Company
    Inventors: Paul Thomas Weisman, Duane Larry Charbonneau, Serena Rae Heyse
  • Publication number: 20180016647
    Abstract: The multiple embodiments described herein comprise the genome of a probiotic Bifidobacterium longum bifidobacteria strain and genes encoded by the genome. Various novel Bifidobacterium longum are described.
    Type: Application
    Filed: August 23, 2017
    Publication date: January 18, 2018
    Inventors: Douwe Van Sinderen, Jun Xu, Wenzhu Zhao, Raymond A. Grant, Yuli Song, Charles Bascom, Duane Larry Charbonneau, Liam O'Mahony
  • Patent number: 9771624
    Abstract: The multiple embodiments described herein comprise the genome of a probiotic Bifidobacterium longum bifidobacteria strain and genes encoded by the genome. Various novel Bifidobacterium longum are described.
    Type: Grant
    Filed: November 11, 2009
    Date of Patent: September 26, 2017
    Assignee: The Procter & Gamble Company
    Inventors: Douwe Van Sinderen, Jun Xu, Wenzhu (Steven) Zhao, Raymond A. Grant, Song Yuli, Charles Bascom, Duane Larry Charbonneau, Liam O'Mahony
  • Publication number: 20160213004
    Abstract: Fibrous structures containing a surface care composition, and more particularly dry fibrous structures containing a surface care composition comprising one or more bacteriophage, methods of making same, and methods for treating surfaces using same are provided.
    Type: Application
    Filed: January 22, 2015
    Publication date: July 28, 2016
    Inventors: Paul Thomas Weisman, Duane Larry Charbonneau, Serena Rae Heyse
  • Patent number: 9289376
    Abstract: A method for identifying test agents that exhibit prebiotic activity on human skin commensal microorganisms and compositions that include such agents. The method includes providing a test culture of a test agent, a human skin commensal microorganism and a minimal carbon medium. The method provides a time efficient and cost effective way to predict in vivo prebiotic activity of a test agent on skin commensal microorganisms.
    Type: Grant
    Filed: November 8, 2012
    Date of Patent: March 22, 2016
    Assignee: The Procter & Gamble Company
    Inventors: Anthony Charles Lanzalaco, Duane Larry Charbonneau, Brian Wilson Howard
  • Patent number: 9271924
    Abstract: A high-throughput, tiered screening method of indentifying test agents that exhibit prebiotic activity on human skin commensal microorganisms and cosmetic compositions that include such agents. The method includes determining the metabolite level of a culture and comparing the metabolite level to a control value. The assay further comprises performing a plate count using the culture when the metabolite level of the culture is greater than its corresponding control value. The plate count results are compared to another control value, and the test agent is identified as a prebiotic agent when the number of colonies present in the plate count assay of the culture is greater than the second control value.
    Type: Grant
    Filed: November 8, 2012
    Date of Patent: March 1, 2016
    Assignee: The Procter & Gamble Company
    Inventors: Anthony Charles Lanzalaco, Duane Larry Charbonneau, Brian Wilson Howard
  • Publication number: 20150374607
    Abstract: A topical cosmetic composition that includes a dermatologically acceptable carrier and an effective amount of a skin commensal prebiotic to improve the health of the skin microbiome, thereby potentially improving the condition and/or appearance of the skin. The topical cosmetic compositions may be made by identifying a potential skin commensal prebiotic agent using a first in vitro assay; confirming the prebiotic potential of an identified prebiotic agent with a second in vitro assay or an in vivo assay; and mixing a confirmed prebiotic agent from and a dermatologically acceptable carrier to form a topical cosmetic composition.
    Type: Application
    Filed: February 12, 2013
    Publication date: December 31, 2015
    Inventors: Anthony Charles LANZALACO, Duane Larry CHARBONNEAU, Brian Wilson HOWARD
  • Publication number: 20150209202
    Abstract: The present disclosure describes disposable absorbent article(s) comprising a skin health composition effective for treating bacteria, including the bacteria associated with diaper rash.
    Type: Application
    Filed: January 22, 2015
    Publication date: July 30, 2015
    Inventors: Paul Thomas WEISMAN, Duane Larry CHARBONNEAU, Serena Rae HEYSE
  • Publication number: 20150209272
    Abstract: A wet wipe product including a fibrous and porous substrate material combined with an aqueous personal care lotion, the lotion including a preservative and an added bacteriophage composition, and methods for making the same, are disclosed. The bacteriophage composition may include one or more bacteriophages that are selected to be effective against one or more respective bacteria strains.
    Type: Application
    Filed: January 22, 2015
    Publication date: July 30, 2015
    Inventors: Paul Thomas Weisman, Duane Larry Charbonneau, Serena Rae Heyse
  • Publication number: 20150202136
    Abstract: The topical use of a skin commensal prebiotic to improve the health of the skin microbiome, thereby potentially improving the condition and/or appearance of the skin, and topical cosmetic compositions that include the skin commensal prebiotic. The topical cosmetic compositions may include a dermatologically acceptable carrier and an effective amount of prebiotic, and may be used in conjunction with one or more oral or topical prebiotics, probiotics and/or probiotic lysates.
    Type: Application
    Filed: February 12, 2013
    Publication date: July 23, 2015
    Inventors: Anthony Charles Lanzalaco, Duane Larry Charbonneau, Brian Wilson Howard
  • Patent number: 8815538
    Abstract: A method for indentifying test agents that exhibit prebiotic activity on human skin commensal microorganisms and cosmetic compositions that include such agents. The method includes providing a test culture of a test agent, a human skin commensal microorganism and a minimal carbon medium. The method provides a time efficient and cost effective way to predict in vivo prebiotic activity of a test agent on skin commensal microorganisms.
    Type: Grant
    Filed: November 8, 2012
    Date of Patent: August 26, 2014
    Assignee: The Procter & Gamble Company
    Inventors: Anthony Charles Lanzalaco, Duane Larry Charbonneau, Brian Wilson Howard
  • Publication number: 20100183559
    Abstract: The multiple embodiments described herein comprise the genome of a probiotic Bifidobacterium longum bifidobacteria strain and genes encoded by the genome. Various novel Bifidobacterium longum are described.
    Type: Application
    Filed: November 11, 2009
    Publication date: July 22, 2010
    Applicants: Alimentary Health Limited, The Procter & Gamble Company
    Inventors: Douwe Van Sinderen, Jun Xu, Wenzhu (Steven) Zhao, Raymond A. Grant, Song Yuli, Charles Bascom, Duane Larry Charbonneau, Liam O'Mahony
  • Publication number: 20080241226
    Abstract: Methods for administering probiotics comprising the steps of: administering a loading dose of a loading probiotic for a loading time period; and administering a dose of a botanical and/or additional materials for the loading time period are disclosed. The methods also include administering a maintenance dose of a maintenance probiotic, and/or a botanical and/or an additional material for a maintenance time period. Also disclosed are kits for use in administering probiotics.
    Type: Application
    Filed: March 27, 2008
    Publication date: October 2, 2008
    Inventors: Susan L. Abeln, Duane Larry Charbonneau, Ker-Sang Chen, James Patrick Ebel, Mary Elaine Freeland
  • Publication number: 20080145341
    Abstract: Stabilised dry bacterial compositions comprising greater than 10% dried bacterial concentrate having a concentration of bacteria of at least 1×108 cfu/g are provided. The compositions have improved stability. Also provided are packaged bacterial compositions, unit-dose compositions and methods of manufacturing the compositions of the present invention.
    Type: Application
    Filed: February 19, 2008
    Publication date: June 19, 2008
    Inventors: Graham John Myatt, Duane Larry Charbonneau, Kevin Ian Trevor Wright, Martin Hallissey
  • Patent number: 6602525
    Abstract: Compositions and kits comprising nitrofurantoin and uva ursi are effective for treating infectious disorders, particularly urinary tract infections, cystitis, and pyelonephritis.
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: August 5, 2003
    Assignee: The Procter & Gamble Company
    Inventors: Kevin Douglas Taylor, Duane Larry Charbonneau
  • Patent number: 6521270
    Abstract: Compositions and kits comprising nitrofurantoin and uva ursi are effective for treating infectious disorders, particularly urinary tract infections, cystitis, and pyclonephritis.
    Type: Grant
    Filed: May 7, 2002
    Date of Patent: February 18, 2003
    Assignee: The Procter & Gamble Company
    Inventors: Kevin Douglas Taylor, Duane Larry Charbonneau